Hypersensitivity pneumonitis related to imatinib mesylate therapy in a patient with chronic myeloid leukemia.

MLA

Kallel, Faten, et al. “Hypersensitivity Pneumonitis Related to Imatinib Mesylate Therapy in a Patient with Chronic Myeloid Leukemia.” Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners, vol. 27, no. 7, Oct. 2021, pp. 1762–65. EBSCOhost, https://doi.org/10.1177/1078155220984239.

APA

Kallel, F., Kassar, O., Maaloul, I., Charfi, M., Ksouda, K., & Elloumi, M. (2021). Hypersensitivity pneumonitis related to imatinib mesylate therapy in a patient with chronic myeloid leukemia. Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners, 27(7), 1762–1765. https://doi.org/10.1177/1078155220984239

Chicago

Kallel, Faten, Olfa Kassar, Imen Maaloul, Maha Charfi, Kamilia Ksouda, and Moez Elloumi. 2021. “Hypersensitivity Pneumonitis Related to Imatinib Mesylate Therapy in a Patient with Chronic Myeloid Leukemia.” Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners 27 (7): 1762–65. doi:10.1177/1078155220984239.